UniProt ID | MRGBP_HUMAN | |
---|---|---|
UniProt AC | Q9NV56 | |
Protein Name | MRG/MORF4L-binding protein | |
Gene Name | MRGBP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 204 | |
Subcellular Localization | Nucleus. | |
Protein Description | Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage.. | |
Protein Sequence | MGEAEVGGGGAAGDKGPGEAATSPAEETVVWSPEVEVCLFHAMLGHKPVGVNRHFHMICIRDKFSQNIGRQVPSKVIWDHLSTMYDMQALHESEILPFPNPERNFVLPEEIIQEVREGKVMIEEEMKEEMKEDVDPHNGADDVFSSSGSLGKASEKSSKDKEKNSSDLGCKEGADKRKRSRVTDKVLTANSNPSSPSAAKRRRT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MGEAEVGGG ------CCCCCCCCC | 42.70 | 19413330 | |
22 | Phosphorylation | KGPGEAATSPAEETV CCCCCCCCCCHHHCE | 42.14 | 28348404 | |
23 | Phosphorylation | GPGEAATSPAEETVV CCCCCCCCCHHHCEE | 19.86 | 25159151 | |
28 | Phosphorylation | ATSPAEETVVWSPEV CCCCHHHCEECCCCH | 16.32 | 28348404 | |
63 | Acetylation | HMICIRDKFSQNIGR EEEEECHHHHCCCCC | 36.75 | 25953088 | |
127 | Sumoylation | VMIEEEMKEEMKEDV CCCCHHHHHHHHHCC | 54.52 | 28112733 | |
145 | Phosphorylation | NGADDVFSSSGSLGK CCHHHHHHCCCCCHH | 24.36 | 26471730 | |
146 | Phosphorylation | GADDVFSSSGSLGKA CHHHHHHCCCCCHHH | 27.53 | 26471730 | |
147 | Phosphorylation | ADDVFSSSGSLGKAS HHHHHHCCCCCHHHC | 31.07 | 25159151 | |
149 | Phosphorylation | DVFSSSGSLGKASEK HHHHCCCCCHHHCHH | 35.58 | 25849741 | |
152 | Acetylation | SSSGSLGKASEKSSK HCCCCCHHHCHHCCC | 54.77 | 23236377 | |
152 | Ubiquitination | SSSGSLGKASEKSSK HCCCCCHHHCHHCCC | 54.77 | 29967540 | |
166 | Phosphorylation | KDKEKNSSDLGCKEG CHHHCCHHHCCCHHH | 46.37 | 28985074 | |
171 | Acetylation | NSSDLGCKEGADKRK CHHHCCCHHHCCHHH | 58.34 | 25953088 | |
183 | Phosphorylation | KRKRSRVTDKVLTAN HHHHHHHCCCEECCC | 29.06 | 24732914 | |
185 | Acetylation | KRSRVTDKVLTANSN HHHHHCCCEECCCCC | 29.76 | 23954790 | |
188 | Phosphorylation | RVTDKVLTANSNPSS HHCCCEECCCCCCCC | 27.12 | 30266825 | |
191 | Phosphorylation | DKVLTANSNPSSPSA CCEECCCCCCCCHHH | 47.88 | 29255136 | |
194 | Phosphorylation | LTANSNPSSPSAAKR ECCCCCCCCHHHHHH | 60.16 | 29255136 | |
195 | Phosphorylation | TANSNPSSPSAAKRR CCCCCCCCHHHHHHC | 24.91 | 29255136 | |
197 | Phosphorylation | NSNPSSPSAAKRRRT CCCCCCHHHHHHCCC | 42.69 | 29255136 | |
200 | Acetylation | PSSPSAAKRRRT--- CCCHHHHHHCCC--- | 46.27 | 25953088 | |
204 | Phosphorylation | SAAKRRRT------- HHHHHCCC------- | 40.94 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MRGBP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MRGBP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MRGBP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191 AND SER-195, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191; SER-194; SER-195AND SER-197, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191 AND SER-195, ANDMASS SPECTROMETRY. |